glp 1 weight loss oral Lilly orforglipron GLP-1 phase 3 trial FDA Approves Oral Semaglutide: First

Semaglutide-treated hepatocytes also had increased expression of genes related to adipocytokine signalling, glucagon signalling, AMPK signalling, insulin signalling, and steroid hormone biosynthesis compared to hepatocytes of vehicle-treated animals ( Figure 6E )

A., Higginbotham, A

Key takeaways GLP-1 agonists are a class of drugs that were originally designed to treat type 2 diabetes, but their use has expanded to include weight loss, heart and kidney disease risk reduction, and management of obstructive sleep apnea

A probiotic strain with published RCT data on weight-management endpoints engages adjacent biology to the medication

The calorie trap is real, and it can happen to anyone, regardless of their knowledge or expertise

Brand-name tirzepatide (Mounjaro, Zepbound) faces similar cost and access barriers, but compounded versions are available through pharmacies including Empower